Please find enclosed the Revised Financial Results along with the additional documents sought by BSE through its email dated 19th June 2026
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 20 Jun 2026, 04:41 PM IST · BSE ID: fcb309d8-648d-4190-b31b-4df8ad9c8b02
View Original BSE Filing (PDF)
💡
In Simple Terms
The company clarified that a specific director was properly authorized to sign its latest annual financial report.
🤖 AI Summary
- Astonea Labs Ltd provided clarification to BSE regarding the authorization for signing its Standalone Financial Results for FY2026.
- Mr. Pardeep Dalal (DIN: 02424111), a Non-Executive Director, was authorized by the Board on May 25, 2026.
- The authorization complies with Regulation 33(2)(b) of SEBI (LODR) Regulations, 2015 for financial results approval.
- This submission clarifies observations from BSE dated June 19, 2026, regarding the initial filing on May 30, 2026.
- The company confirmed no other information from the May 30, 2026 announcement, including XBRL filing, has changed.
🏢 How This Affects the Company
The company has addressed a regulatory observation from BSE, mitigating a compliance risk regarding the authorization of financial results.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are informed that the company has clarified its compliance process for approving and signing financial results for the financial year ended March 31, 2026.
🔍
Management Signal
Management is signaling its commitment to regulatory compliance by promptly addressing observations from the BSE regarding financial reporting procedures.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Review the full Standalone Financial Results for FY26 to understand performance metrics.
Monitor future regulatory filings for Astonea Labs Ltd concerning financial reporting compliance.
Observe any subsequent communications from BSE regarding Astonea Labs Ltd's filings.
LOW RISK
The filing addresses a procedural compliance matter, which is now resolved through clarification.
💡 Investor Takeaway
Astonea Labs Limited confirmed that Mr. Pardeep Dalal (DIN: 02424111) was duly authorized on May 25, 2026, to sign the Standalone Financial Results for the financial year ended March 31, 2026, addressing a BSE observation. No financial numbers are provided in this filing.
⚖️ Strengths & Concerns
✅ Positives
- Management has demonstrated responsiveness by promptly clarifying the authorization for financial results as sought by BSE.
- The board formally authorized Mr. Pardeep Dalal (DIN: 02424111) to sign financial results, aligning with SEBI Regulation 33(2)(b).
⚠️ Concerns
- The initial submission of financial results on May 30, 2026, required a clarification from BSE, indicating a potential procedural observation.
- The filing does not provide any financial figures or performance data for the financial year ended March 31, 2026.
📅 Company Track Record
Astonea Labs Ltd was incorporated on November 03, 2017, and was formerly known as Astonea Labs Private Limited. Limited public track record is available. The company listed on BSE as 544409. This is the first filing context found.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was the purpose of Astonea Labs Ltd's filing on June 20, 2026?
Astonea Labs Ltd's filing was to provide a clarification letter on discrepancies in financial results, specifically regarding the authorization for signing the Standalone Financial Results for the financial year ended March 31, 2026.
Who was authorized to sign Astonea Labs Ltd's financial results for FY2026?
Mr. Pardeep Dalal (DIN: 02424111), a Non-Executive Director of Astonea Labs Ltd, was authorized by the Board of Directors on May 25, 2026, to sign the financial results for the financial year ended March 31, 2026.
Did Astonea Labs Ltd change any financial information in its previous May 30, 2026 announcement?
No, Astonea Labs Ltd confirmed that there is no change in the remaining information as disclosed in its earlier announcement dated May 30, 2026, including the XBRL filing made in this regard.
Questions based on this BSE filing only. For information purposes.